A5098670848- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis C virus research
- Liver physiology and pathology
- Lung Cancer Research Studies
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
Groote Schuur Hospital
2024-2025
University of Cape Town
2024-2025
This study explores the epidemiology, treatment and outcomes of hepatocellular carcinoma (HCC) in a sub-Saharan cohort, comparing patients with without human immunodeficiency virus (HIV). A retrospective cohort treated for HCC from 1 February 2011 to 29 2024 at Groote Schuur Hospital, South Africa was performed. Of 501 patients, 75 (15.0 %) were people living HIV (PLWH). The PLWH younger (43.7 ± 9.7 vs. 52.9 15.3 years, p < 0.00001), had more frequent chronic hepatitis B (HBV) co-infection...
ABSTRACT Background The impact of healthcare disparities on the outcomes for hepatocellular carcinoma (HCC) has not been explored in South Africa. This study aims to evaluate and compare presentation, treatment, HCC a cohort patients treated public private sectors. Methods records 551 consecutive at hospital compared those 51 sector from 1 December 2001 29 February 2024 were retrospectively reviewed. Results Patients managed significantly younger (mean age: 49.6 ± 14.8 vs. 59.6 14.3 years, p...
Jaundice is a marker of advanced disease and poor outcomes in hepatocellular carcinoma (HCC). The aim this study was to describe analyse the management jaundiced HCC patients at large academic referral centre sub-Saharan Africa (SSA).
Surgical resection of distal cholangiocarcinoma (dCCA) offers the only chance for cure and long-term survival. The current literature provides limited data regarding surgical management outcomes dCCA. This study aims to describe presentation, management, dCCA at a large academic referral centre in South Africa.